My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
RES-2022-168
>
Meetings
>
2022
>
09. September
>
2022-09-06 10:00 AM - Commissioners' Agenda
>
RES-2022-168
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
9/13/2022 11:54:56 AM
Creation date
9/13/2022 11:53:49 AM
Metadata
Fields
Template:
Meeting
Date
9/6/2022
Meeting title
Commissioners' Agenda
Location
Commissioners' Auditorium
Address
205 West 5th Room 109 - Ellensburg
Meeting type
Regular
Meeting document type
Fully Executed Version
Supplemental fields
Item
Request to Approve a Resolution Authorizing the Chair's Signature on a Opioid Litigation Allocation Agreement
Order
3
Placement
Consent Agenda
Row ID
93293
Type
Agreement
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
107
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
FINAL AGREEMENT 3.25.22 <br />intervention services, and to support training and technical assistance and other <br />strategies to abate the opioid epidemic described in this opioid abatement strategy <br />list. <br />A dashboard to (a) share reports, recommendations, or plans to spend opioid <br />settlement funds; (b) to show how opioid settlement funds have been spent; (c) to <br />report program or strategy outcomes; or (d) to track, share or visualize key opioid- <br />or health-related indicators and supports as identified through collaborative <br />statewide, regional, local or community processes. <br />Invest in infrastructure or staffing at govemment or not-for-profit agencies to <br />support collaborative, cross-system coordination with the purpose of preventing <br />overprescribing, opioid misuse, or opioid overdoses, treating those with OUD and <br />any co-occurring SUD/MH conditions, supporting them in treatment or recovery, <br />connecting them to care, or implementing other strategies to abate the opioid <br />epidemic described in this opioid abatement strategy list. <br />4 Provide resources to staff government oversight and management of opioid <br />abatement programs. <br />K. TRAINING <br />In addition to the training referred to throughout this document, support training to abate <br />the opioid epidemic through activities, programs, or strategies that may include, but are <br />not limited to, those that: <br />Provide funding for staff training or networking programs and services to improve <br />the capability of government, community, and not-for-profit entities to abate the <br />opioid crisis. <br />Support infrastructure and staffing for collaborative cross-system coordination to <br />prevent opioid misuse, prevent overdoses, and treat those with OUD and any co- <br />occurring SUD/MH conditions, or implement other strategies to abate the opioid <br />epidemic described in this opioid abatement strategy list (e.g., health care, <br />primary care, pharmacies, PDMPs, etc.). <br />L. RESEARCH <br />Support opioid abatement research that may include, but is not limited to, the following: <br />Monitoring, surveillance, data collection and evaluation of programs and <br />strategies described in this opioid abatement strategy list. <br />2. Research non-opioid treatment of chronic pain <br />Research on improved service delivery for modalities such as SBIRT that <br />demonstrate promising but mixed results in populations vulnerable to <br />opioid use disorders. <br />2. <br />J <br />1 <br />2 <br />5 <br />E-14
The URL can be used to link to this page
Your browser does not support the video tag.